The treatment protected mice against the poison of the common taipans, as well as other snake species
Matthijs Kuijpers/Alamy
An antibody -based snake antivenom from a hyperimmune man seems to be effective against multiple species bites, which increases the possibility that a universal treatment may be within reach.
Snake bites cause up to 137000 deaths a year and about three times more amputations and disabilities. Antivivens are currently created for individual snake species that use sheep or horses antibodies that have a leg displayed in their poison.
But the infusion of non -human antibodies can cause serious side effects, such as allergic reactions that prolong life. It also means that the snake response for a bite must identify before an antiquity can be administered.
Jacob Glanville of the Centivax Biotechnology firm in San Francisco, California, and his colleagues seek widely neutralization antibodies that could become an antivennene that works against many, or all, poisonous snakes. “Although there are 650 species of poisonous snakes, its entire poison uses the same 10 general classes of toxins,” says Glanville.
The researchers first looked for someone who had been bitten several times by different snakes. “Maybe a clumsy snake researcher,” says Glanville. Then he heard media reports on Tim Friede, who, according to his online biography, has “self -administered more than 700 doses of snake venom of the most mortal snakes in the world.”
“If someone could have generated neutralization antibodies against snake poison, Tim Friede’s bone would have,” says Glanville.
Of 40 milliliters of Blood of Friede, the team turned its “immune memory into a library of thousands of millions of antibodies,” he says. The promising candidates were evaluated in mice that had exposed to the leg to the 19th venom of the list of world health organizations of the most dangerous species of the Elapidae family, including several species of Cobra.
At all times, two Friede blood antibodies, called LNX-D09 and SNX-B03, along with a toxin inhibitor called Varespladib, became a treatment. When this was tested in mice, it provides full protection against 13 of the species, including several types of cobra, the tiger snake (Nochis Scutatus) and the common taipan (Oxiurano Sctellatus). It also demonstrated partial protection against the six traninal species, including the common death addor (Antarctic Acanthophis).
The next step is to test the treatment in animals that are taken to fat clinics in Australia after a snake bite, and find antibodies that provide coverage against Vipers.
Tian du, from the University of Sydney, Australia, says that “finding only two antibodies (with an inhibitor) that can cover that spectrum of snakes await universal treatment in the near future.”
But Du, who discovered that the heparin of drugs that give it blood, people could lose limbs after cobra bites, embrace if equipment treatment can prevent skin necrosis and muscles.
Topics:
]